Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3; the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T20:18:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The update adds Revision: v3.4.2 and removes the earlier government-funding notice (v3.4.1), a minor maintenance update to the page.
    Difference
    0.5%
    Check dated 2026-02-11T09:25:05.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A government-funding lapse notice was added, directing users to cc.nih.gov and opm.gov for updates. A new Revision: v3.4.1 banner replaces the previous v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T05:42:10.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page includes minor UI/copy updates, including a new Show glossary option, capitalization tweaks (No FEAR Act data; Last Update Submitted that Met QC Criteria), and a Revision: v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:21:20.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T01:25:24.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Footer updates include removal of HHS Vulnerability Disclosure and addition of Revision: v3.3.3; these are minor site maintenance updates and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T22:31:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.